迪安診斷(300244.SZ):凱萊譜擬增資1.5億元引進財務投資人高瓴、德福及松禾
格隆匯 1 月 8日丨迪安診斷(300244.SZ)公佈,公司控股子公司杭州凱萊譜精準醫療檢測技術有限公司(“凱萊譜”或“目標公司”)擬增資1.5億元人民幣引進3個財務投資人,其他股東放棄優先認購權。其中,珠海高瓴悠恆股權投資合夥企業(有限合夥)(“高瓴”)、廈門德福悦安投資合夥企業(有限合夥)(“德福”)、深圳市松禾成長四號股權投資合夥企業(有限合夥)(“松禾”)分別擬以現金形式向凱萊譜增資8000萬元人民幣、5000萬元人民幣、2000萬元人民幣。
此次增資完成後,高瓴、德福、松禾分別持有凱萊譜7.6190%、4.7619%、1.9048%的股權。此次增資完成後,迪安診斷持有凱萊譜的股權從47.8961%降至41.0538%,公司仍為其控股股東並繼續將其納入合併報表範圍。此次增資設有交割條件和不超過90天的過渡期,最終能否完成增資存在不確定性。
在下一輪面向VC或PE等財務性投資人的融資中,在同等條件下,前輪投資人保留前輪增資協議中約定的2000萬元人民幣的投資額度,給予高瓴3810萬元人民幣的投資額度,給予德福2381萬元人民幣的投資額度,給予松禾952萬元人民幣的投資額度。為避免疑義,除非迪安主動放棄對目標公司的控制權,該等特殊增資權的行使不應影響迪安診斷對目標公司的控制權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.